A phase II trial of induction chemotherapy with cisplatin, docetaxel, and capecitabine followed by concurrent cisplatin-radiotherapy in advanced nasopharyngeal carcinoma.

被引：1
|
作者：
Yamouni, M.
Beldjilali, Y.
Benhadji, K. A.
Khellafi, H.
Betkaoui, F.
Kaid, Y.
Benchlef, L.
Daim, F. Z.
Toubal, S.
Boukerche, A.
Abdelaoui, A.
Djellali, L.
机构：
[1] Univ Hosp Oran, Dept Oncol, Oran, Algeria
[2] Univ Hosp Oran, Dept Med Oncol, Oran, Algeria
[3] Univ Hosp Oran, Dept Radiotherapy, Oran, Algeria
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5543
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5543
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Overall survival after concurrent cisplatin-radiotherapy compared with radiotherapy alone in locoregionally advanced nasopharyngeal carcinoma
    Wittlinger, M
    STRAHLENTHERAPIE UND ONKOLOGIE, 2006, 182 (02) : 119 - 121
  • [32] Clinical value of docetaxel plus cisplatin (TP) induction chemotherapy followed by TP concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma
    Tao, Hao-Yun
    Zhan, Ze-Jiang
    Qiu, Wen-Ze
    Liao, Kai
    Yuan, Ya-Wei
    Yuan, Tai-Ze
    Zheng, Rong-Hui
    JOURNAL OF CANCER, 2021, 12 (01): : 18 - 27
  • [33] Induction chemotherapy with cisplatin and gemcitabine followed by accelerated radiotherapy and concurrent cisplatin in patients with stage IV(A-B) nasopharyngeal carcinoma
    Yau, Tsz-Kok
    Lee, Anne Wing-Mul
    Wong, Dominique Hiu-Ming
    Yeung, Rebecca Mei-Wan
    Chan, Elian Wing-Kin
    Ng, Wai-Tong
    Tong, Macy
    Soong, Inda Sung
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2006, 28 (10): : 880 - 887
  • [34] Comparison of concurrent chemoradiation therapy plus induction chemotherapy with cisplatin, fluorouracil and docetaxel versus gemcitabine and cisplatin in advanced nasopharyngeal carcinoma
    Zeng, Z.
    Yan, R.
    Tu, L.
    Wang, Y.
    Chen, P.
    Luo, F.
    Liu, L.
    ANNALS OF ONCOLOGY, 2018, 29
  • [35] Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China
    Zang, Jian
    Xu, Man
    Li, Chen
    Zhao, Lina
    Luo, Shanuan
    Wang, Jianhua
    Shi, Mei
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2020, 146 (09) : 2369 - 2378
  • [36] INDUCTION CHEMOTHERAPY (CT) WITH DOCETAXEL, CISPLATIN, AND FLUOROURACIL (TPF) FOLLOWED BY CONCOMITANT CISPLATIN PLUS RADIOTHERAPY IN LOCALLY ADVANCED NASOPHARYNGEAL CANCER (NPC)
    Kerboua, E.
    Lagha, N.
    Bouzid, K.
    Chami, S.
    Mekki, F.
    ANNALS OF ONCOLOGY, 2010, 21 : 324 - 324
  • [37] Gemcitabine and cisplatin versus docetaxel and cisplatin as induction chemotherapy followed by concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma from non-endemic area of China
    Jian Zang
    Man Xu
    Chen Li
    Lina Zhao
    Shanuan Luo
    Jianhua Wang
    Mei Shi
    Journal of Cancer Research and Clinical Oncology, 2020, 146 : 2369 - 2378
  • [38] Phase II trial of combination docetaxel and cisplatin in patients with locally advanced nasopharyngeal carcinoma
    Yamouni, M.
    Benhadji, K. A.
    Beldjilali, Y.
    Lahfa, I.
    Khellafi, H.
    Abdelaoui, A.
    Djellali, L.
    Bouzid, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [39] Low-Dose Fractionated Radiation with Induction Docetaxel and Cisplatin Chemotherapy followed by Concurrent Cisplatin and Radiation Therapy in Locally Advanced Nasopharyngeal Cancer, Randomized Phase II-III Trial.
    Al-Rajhi, N. M.
    Abdelrahman, E. M.
    Ahmad, S.
    Soudy, H.
    AlGhazi, M.
    Al Shabanah, M. O.
    Memon, M.
    Khafaga, Y. M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2019, 105 (01): : E387 - E387
  • [40] Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: A phase II trial
    Umanzor, J
    Aguiluz, M
    Pineda, C
    Andrade, S
    Erazo, M
    Flores, C
    Santillana, S
    GYNECOLOGIC ONCOLOGY, 2006, 100 (01) : 70 - 75
12345